These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
170 related items for PubMed ID: 28747156
1. Influence of chemotherapeutic drug-related gene polymorphisms on toxicity and survival of early breast cancer patients receiving adjuvant chemotherapy. Ludovini V, Antognelli C, Rulli A, Foglietta J, Pistola L, Eliana R, Floriani I, Nocentini G, Tofanetti FR, Piattoni S, Minenza E, Talesa VN, Sidoni A, Tonato M, Crinò L, Gori S. BMC Cancer; 2017 Jul 26; 17(1):502. PubMed ID: 28747156 [Abstract] [Full Text] [Related]
2. GSTT1, GSTM1, and GSTP1 polymorphisms and chemotherapy response in locally advanced breast cancer. Oliveira AL, Rodrigues FF, Santos RE, Aoki T, Rocha MN, Longui CA, Melo MB. Genet Mol Res; 2010 Jun 11; 9(2):1045-53. PubMed ID: 20568049 [Abstract] [Full Text] [Related]
3. Influence of thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms on the disease-free survival of breast cancer patients receiving adjuvant 5-fluorouracil/methotrexate-based therapy. Paré L, Altés A, Ramón y Cajal T, Del Rio E, Alonso C, Sedano L, Barnadas A, Baiget M. Anticancer Drugs; 2007 Aug 11; 18(7):821-5. PubMed ID: 17581305 [Abstract] [Full Text] [Related]
4. Genetic Polymorphisms in Glutathione S-Transferase (GST) Gene and Their Correlation with Toxicity of Chemotherapy in Breast Cancer Patients. Gudur RA, Bhosale SJ, Gudur AK, Datkhile KD. Asian Pac J Cancer Prev; 2024 Jul 01; 25(7):2271-2282. PubMed ID: 39068558 [Abstract] [Full Text] [Related]
5. Glutathione S-transferase polymorphisms influence chemotherapy response and treatment outcome in breast cancer. Wang J, Wang T, Yin GY, Yang L, Wang ZG, Bu XB. Genet Mol Res; 2015 Sep 22; 14(3):11126-32. PubMed ID: 26400343 [Abstract] [Full Text] [Related]
6. Influences of ERCC1, ERCC2, XRCC1, GSTP1, GSTT1, and MTHFR polymorphisms on clinical outcomes in gastric cancer patients treated with EOF chemotherapy. Liu R, Zhao X, Liu X, Chen Z, Qiu L, Geng R, Guo W, He G, Yin J, Li J, Zhu X. Tumour Biol; 2016 Feb 22; 37(2):1753-62. PubMed ID: 26314858 [Abstract] [Full Text] [Related]
8. Gene polymorphisms in cyclophosphamide metabolism pathway,treatment-related toxicity, and disease-free survival in SWOG 8897 clinical trial for breast cancer. Yao S, Barlow WE, Albain KS, Choi JY, Zhao H, Livingston RB, Davis W, Rae JM, Yeh IT, Hutchins LF, Ravdin PM, Martino S, Lyss AP, Osborne CK, Abeloff M, Hortobagyi GN, Hayes DF, Ambrosone CB. Clin Cancer Res; 2010 Dec 15; 16(24):6169-76. PubMed ID: 21169260 [Abstract] [Full Text] [Related]
9. Genetic polymorphisms associated with adverse events and elimination of methotrexate in childhood acute lymphoblastic leukemia and malignant lymphoma. Imanishi H, Okamura N, Yagi M, Noro Y, Moriya Y, Nakamura T, Hayakawa A, Takeshima Y, Sakaeda T, Matsuo M, Okumura K. J Hum Genet; 2007 Dec 15; 52(2):166-171. PubMed ID: 17180579 [Abstract] [Full Text] [Related]
11. GSTP1, GSTM1, and GSTT1 polymorphisms as predictors of response to chemotherapy in patients with breast cancer: a meta-analysis. Kong X, Li Z, Li X. Cancer Chemother Pharmacol; 2016 Dec 15; 78(6):1163-1173. PubMed ID: 27785604 [Abstract] [Full Text] [Related]
12. Clinical implications of glutathione S-transferase genotyping in patients with diffuse large B-cell lymphoma. Atanaskovic L, Cikota-Aleksic B, Tarabar O, Trimcev J, Zivanovic-Ivic A, Marjanovic S, Magic Z. J BUON; 2016 Dec 15; 21(6):1459-1465. PubMed ID: 28039708 [Abstract] [Full Text] [Related]
13. Individual and combined effects of GSTM1, GSTT1, and GSTP1 polymorphisms on breast cancer risk: A meta-analysis and re-analysis of systematic meta-analyses. Miao LF, Ye XH, He XF. PLoS One; 2020 Dec 15; 15(3):e0216147. PubMed ID: 32155154 [Abstract] [Full Text] [Related]
14. Genetic polymorphism of lysyl oxidase, glutathione S-transferase M1, glutathione-S-transferase T1, and glutathione S-transferase P1 genes as risk factors for lung cancer in Egyptian patients. El-Deek SEM, Abdel-Ghany SM, Hana RS, Mohamed AAR, El-Melegy NT, Sayed AA. Mol Biol Rep; 2021 May 15; 48(5):4221-4232. PubMed ID: 34052967 [Abstract] [Full Text] [Related]
15. Predictive potential role of glutathione S-transferase polymorphisms in the prognosis of breast cancer. Wang X, Huang ZH. Genet Mol Res; 2015 Aug 28; 14(3):10236-41. PubMed ID: 26345960 [Abstract] [Full Text] [Related]
16. Glutathione S-Transferase Gene Polymorphisms and Treatment Outcome in Cervical Cancer Patients under Concomitant Chemoradiation. Abbas M, Kushwaha VS, Srivastava K, Banerjee M. PLoS One; 2015 Aug 28; 10(11):e0142501. PubMed ID: 26571237 [Abstract] [Full Text] [Related]
17. Frequency and Association Of GSTM1 and GSTT1 Gene Polymorphisms with Survival in Breast Cancer Patients. Tangkhuenkhan P, Harncharoen K, Thanasitthichai S, Tiwawech D, Purisa W, Saelee P, Wattanalai R. Asian Pac J Cancer Prev; 2020 Aug 01; 21(8):2251-2257. PubMed ID: 32856852 [Abstract] [Full Text] [Related]
19. Genetic polymorphisms in GST genes and survival of colorectal cancer patients treated with chemotherapy. Funke S, Timofeeva M, Risch A, Hoffmeister M, Stegmaier C, Seiler CM, Brenner H, Chang-Claude J. Pharmacogenomics; 2010 Jan 01; 11(1):33-41. PubMed ID: 20017670 [Abstract] [Full Text] [Related]
20. The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescue. Chiusolo P, Giammarco S, Bellesi S, Metafuni E, Piccirillo N, De Ritis D, Marietti S, Federica S, Laurenti L, Fianchi L, Hohaus S, Giuseppe L, Sica S. Cancer Chemother Pharmacol; 2012 Mar 01; 69(3):691-6. PubMed ID: 21984221 [Abstract] [Full Text] [Related] Page: [Next] [New Search]